Search research articles
Contact Us
Filters
Showing results (101-110 of 208) with videos related to
Page
of 21
Sort By:
Clinical Lung Cancer
|
April 8, 2022
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed
Christine A Ciunci, Jacob B Reibel, Tracey L Evans, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 2014
Late consequential surgical bed soft tissue necrosis in advanced oropharyngeal squamous cell carcinomas treated with transoral robotic surgery and postoperative radiation therapy
J Nicholas Lukens, Alexander Lin, Victoria Gamerman, et al.
Head & Neck
|
February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies
Noel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
The Laryngoscope
|
May 2, 2023
Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy
Joseph S Lu, Austin C Cao, David Shimunov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2010
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer
Eric B Haura, Alejandro D Ricart, Timothy G Larson, et al.
BMC Cancer
|
October 12, 2021
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
Vivek Nimgaonkar, Charu Aggarwal, Abigail T Berman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2007
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
Anthony W Tolcher, Monica Mita, Neal J Meropol, et al.
JAMA Oncology
|
July 12, 2019
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial
Joshua M Bauml, Rosemarie Mick, Christine Ciunci, et al.
Cancer
|
September 14, 2012
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P Patel, Alexander J Lazar, Nicholas E Papadopoulos, et al.
Head & Neck
|
September 9, 2014
HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery
John M Kaczmar, Kay See Tan, Daniel F Heitjan, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 208) with videos related to
Sort By:
Page
of 21
Clinical Lung Cancer
|
April 8, 2022
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed
Christine A Ciunci, Jacob B Reibel, Tracey L Evans, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 2014
Late consequential surgical bed soft tissue necrosis in advanced oropharyngeal squamous cell carcinomas treated with transoral robotic surgery and postoperative radiation therapy
J Nicholas Lukens, Alexander Lin, Victoria Gamerman, et al.
Head & Neck
|
February 19, 2005
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies
Noel M Kramer, Eric M Horwitz, Jonathan Cheng, et al.
The Laryngoscope
|
May 2, 2023
Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy
Joseph S Lu, Austin C Cao, David Shimunov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2010
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer
Eric B Haura, Alejandro D Ricart, Timothy G Larson, et al.
BMC Cancer
|
October 12, 2021
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
Vivek Nimgaonkar, Charu Aggarwal, Abigail T Berman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2007
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
Anthony W Tolcher, Monica Mita, Neal J Meropol, et al.
JAMA Oncology
|
July 12, 2019
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial
Joshua M Bauml, Rosemarie Mick, Christine Ciunci, et al.
Cancer
|
September 14, 2012
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P Patel, Alexander J Lazar, Nicholas E Papadopoulos, et al.
Head & Neck
|
September 9, 2014
HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery
John M Kaczmar, Kay See Tan, Daniel F Heitjan, et al.
Page
of 21